Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's documentation or styling. This change represents an internal version update rather than a substantive alteration to user-facing content.
    Difference
    0.1%
    Check dated 2026-08-30T15:41:54.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.5, indicating a new published revision of the page. This update does not modify the study content or details.
    Difference
    0.1%
    Check dated 2026-08-08T23:27:49.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.3 to v3.6.4. This indicates a newer version of the page with minor updates or fixes.
    Difference
    0.1%
    Check dated 2026-07-25T16:03:57.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.3) replacing the previous v3.6.2, indicating a small maintenance update.
    Difference
    0.1%
    Check dated 2026-07-04T04:12:42.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.2, signaling a small backend/template update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-27T02:13:47.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Recruitment status now indicates the study is not enrolling; new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a standardized Intervention/Treatment heading with an updated Revision: v3.6.0 are added, while an older Intervention / Treatment heading and the previous revision label are removed.
    Difference
    0.4%
    Check dated 2026-06-12T16:37:36.000Z thumbnail image

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.